Molybdenum Cofactor Deficiency, Type A
4 clinical trials · Condition
◉ Watch Molybdenum Cofactor Deficiency, Type A
| Record | Firm | Date |
|---|---|---|
| Early Check: Expanded Screening in Newborns (NCT03655223) | RTI International | 2018-10-15 |
| Study of ORGN001 (Formerly ALXN1101) in Neonates, Infants and Children With Molybdenum Cofactor Deficiency (MOCD) Type A (NCT02629393) | Origin Biosciences | 2016-05-01 |
| Safety & Efficacy Study of ORGN001 (Formerly ALXN1101) in Pediatric Patients With MoCD Type A Currently Treated With rcPMP (NCT02047461) | Origin Biosciences | 2014-04-01 |
| Study of cPMP (Precusor Z) to Treat Molybdenum Cofactor Deficiency (MoCD) Type A (NCT00957749) | Orphatech Pharmaceuticals, GmbH | 2009-08-01 |
Track Molybdenum Cofactor Deficiency, Type A automatically
Every clearance here is in the API, with alerts when new ones post.